Overdosage symptoms are those of heavy metal toxicity; they include pruritus, dermatitis, stomatitis, vague gastrointestinal discomfort, albuminuria with or without a nephrotic syndrome, hematuria, agranulocytosis, thrombocytopenic purpura, and aplastic anemia.
Sodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects. Gold Sodium Thiomalate is supplied as a solution for intramuscular injection containing 50 mg of Gold Sodium Thiomalate per mL. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Irinotecan | The risk or severity of neutropenia can be increased when Sodium aurothiomalate is combined with Irinotecan. |
| Ramipril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Ramipril is combined with Sodium aurothiomalate. |
| Fosinopril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Fosinopril is combined with Sodium aurothiomalate. |
| Trandolapril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Trandolapril is combined with Sodium aurothiomalate. |
| Benazepril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Benazepril is combined with Sodium aurothiomalate. |
| Enalapril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Enalapril is combined with Sodium aurothiomalate. |
| Moexipril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Moexipril is combined with Sodium aurothiomalate. |
| Lisinopril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Lisinopril is combined with Sodium aurothiomalate. |
| Perindopril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Perindopril is combined with Sodium aurothiomalate. |
| Quinapril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Quinapril is combined with Sodium aurothiomalate. |
| Omapatrilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Omapatrilat is combined with Sodium aurothiomalate. |
| Rescinnamine | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Rescinnamine is combined with Sodium aurothiomalate. |
| Captopril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Captopril is combined with Sodium aurothiomalate. |
| Cilazapril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Cilazapril is combined with Sodium aurothiomalate. |
| Spirapril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Spirapril is combined with Sodium aurothiomalate. |
| Temocapril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Temocapril is combined with Sodium aurothiomalate. |
| Enalaprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Enalaprilat is combined with Sodium aurothiomalate. |
| Imidapril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Imidapril is combined with Sodium aurothiomalate. |
| Zofenopril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Zofenopril is combined with Sodium aurothiomalate. |
| Delapril | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Delapril is combined with Sodium aurothiomalate. |
| Benazeprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Benazeprilat is combined with Sodium aurothiomalate. |
| Fosinoprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Fosinoprilat is combined with Sodium aurothiomalate. |
| Ramiprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Ramiprilat is combined with Sodium aurothiomalate. |
| Trandolaprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Trandolaprilat is combined with Sodium aurothiomalate. |
| Moexiprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Moexiprilat is combined with Sodium aurothiomalate. |
| Perindoprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Perindoprilat is combined with Sodium aurothiomalate. |
| Quinaprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Quinaprilat is combined with Sodium aurothiomalate. |
| Cilazaprilat | The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Cilazaprilat is combined with Sodium aurothiomalate. |
| Cyclosporine | Cyclosporine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Icosapent | Icosapent may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefotiam | Cefotiam may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Mesalazine | Mesalazine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefmenoxime | Cefmenoxime may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefmetazole | Cefmetazole may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Pamidronic acid | Pamidronic acid may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Tenofovir disoproxil | Tenofovir disoproxil may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cidofovir | Cidofovir may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefpiramide | Cefpiramide may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Ceftazidime | Ceftazidime may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Loracarbef | Loracarbef may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefalotin | Cefalotin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Nabumetone | Nabumetone may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Ketorolac | Ketorolac may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Tenoxicam | Tenoxicam may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Celecoxib | Celecoxib may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefotaxime | Cefotaxime may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Tolmetin | Tolmetin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Foscarnet | Foscarnet may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Rofecoxib | Rofecoxib may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Piroxicam | Piroxicam may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Methotrexate | Methotrexate may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cephalexin | Cephalexin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Fenoprofen | Fenoprofen may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Valaciclovir | Valaciclovir may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Valdecoxib | Valdecoxib may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Sulindac | Sulindac may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Bacitracin | Bacitracin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Amphotericin B | Amphotericin B may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cephaloglycin | Cephaloglycin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Adefovir dipivoxil | Adefovir dipivoxil may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Pentamidine | Pentamidine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Etodolac | Etodolac may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Mefenamic acid | Mefenamic acid may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Acyclovir | Acyclovir may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Sulfasalazine | Sulfasalazine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Phenylbutazone | Phenylbutazone may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Meloxicam | Meloxicam may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Carprofen | Carprofen may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefaclor | Cefaclor may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Diflunisal | Diflunisal may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Tacrolimus | Tacrolimus may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Ceforanide | Ceforanide may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Salicylic acid | Salicylic acid may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Meclofenamic acid | Meclofenamic acid may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Acetylsalicylic acid | Acetylsalicylic acid may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Carboplatin | Carboplatin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Oxaprozin | Oxaprozin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Balsalazide | Balsalazide may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefditoren | Cefditoren may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Atazanavir | Atazanavir may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Colistimethate | Colistimethate may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefuroxime | Cefuroxime may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefapirin | Cefapirin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefadroxil | Cefadroxil may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefprozil | Cefprozil may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Ceftriaxone | Ceftriaxone may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Olsalazine | Olsalazine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Lumiracoxib | Lumiracoxib may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefamandole | Cefamandole may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefazolin | Cefazolin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefonicid | Cefonicid may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefoperazone | Cefoperazone may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefotetan | Cefotetan may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefoxitin | Cefoxitin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Ceftizoxime | Ceftizoxime may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefradine | Cefradine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Magnesium salicylate | Magnesium salicylate may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Salsalate | Salsalate may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Choline magnesium trisalicylate | Choline magnesium trisalicylate may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |
| Cefepime | Cefepime may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level. |